Amylyx Pharmaceuticals (AMLX)

• Market cap: $1.49B
• 1 day: -0.85%
• 5 days: -4.78%
• 1 month: 2.5%
• 3 months: 73.47%
• 6 months: 172.6%
• Year to date: 256.27%
• 1 year: 157.96%
• 5 years: -22.91%
• 10 years: -22.91%
• Sector: Healthcare
• Industry: Biotechnology

About: Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.

Employees: 123